Statistics for Aquestive Therapeutics (id:6874 AQST)

Valuation metrics

Market cap

404.83M

Enterprise value

363.81M

Trailing P/E (ttm)

-36.42

Forward P/E

-7.40

PEG ratio

-7.40

Price/Sales (ttm)

6.87

Price/Book (mrq)

-9.50

Enterprise Value/Revenue

6.18

Enterprise Value/EBITDA

-18.16

Overview

Shares outstanding

91.18M

Float

80.10M

Shares short

10.14M

% Held by insiders

0.05%

% Held by institutions

0.52%

Average volume (10 days)

1.95M

Average volume (90 days)

Price summary

52-Week low

1.84

52-Week high

6.23

52-Week change

55.23%

Beta

2.82

50-Day moving average

4.99

200-Day moving average

3.90

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-59.75%

Operating margin

-61.22%

Operational effectiveness

Return on assets

-15.57%

Return on equity

7.39%

Income statement

Revenue (ttm)

0.73

Revenue per share (ttm)

0.73

Quarterly revenue growth (yoy)

Gross profit (ttm)

29.75M

EBITDA

2.56M

Net income to common (ttm)

-35,193,000.00

Diluted EPS (ttm)

-0.45

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

77.89M

Total cash per share (mrq)

0.85

Total debt (mrq)

36.87M

Total Debt/Equity (mrq)

-0.81

Current ratio (mrq)

637.30%

Book value per share (mrq)

-0.50

Cash flow

Cash flow statement

-34,212,000.00

Levered free cash flow (LFCF)

-12,320,875.00